Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions

por Schmid, Ingrid, Bonnington, Lea, Gerl, Monika, Bomans, Katrin, Thaller, Anna Louisa, Wagner, Katharina, Schlothauer, Tilman, Falkenstein, Roberto, Zimmermann, Boris, Kopitz, Jürgen, Hasmann, Max, Bauss, Frieder, Haberger, Markus, Reusch, Dietmar, Bulau, Patrick
Publicado 2018

Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab

por Ibarrondo, F. Javier, Yang, Otto O., Chodon, Thinle, Avramis, Earl, Lee, Yohan, Sazegar, Hooman, Jalil, Jason, Chmielowski, Bartosz, Koya, Richard C., Schmid, Ingrid, Gomez-Navarro, Jesus, Jamieson, Beth D., Ribas, Antoni, Comin-Anduix, Begoña
Publicado 2013